JP4839051B2 - 核酸プローブを用いる被検物質の検出方法 - Google Patents
核酸プローブを用いる被検物質の検出方法 Download PDFInfo
- Publication number
- JP4839051B2 JP4839051B2 JP2005274912A JP2005274912A JP4839051B2 JP 4839051 B2 JP4839051 B2 JP 4839051B2 JP 2005274912 A JP2005274912 A JP 2005274912A JP 2005274912 A JP2005274912 A JP 2005274912A JP 4839051 B2 JP4839051 B2 JP 4839051B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- test substance
- acid probe
- complex
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000126 substance Substances 0.000 title claims description 202
- 238000012360 testing method Methods 0.000 title claims description 173
- 108020004711 Nucleic Acid Probes Proteins 0.000 title claims description 143
- 239000002853 nucleic acid probe Substances 0.000 title claims description 143
- 238000000034 method Methods 0.000 title claims description 54
- 239000003446 ligand Substances 0.000 claims description 115
- 102000039446 nucleic acids Human genes 0.000 claims description 102
- 108020004707 nucleic acids Proteins 0.000 claims description 102
- 150000007523 nucleic acids Chemical class 0.000 claims description 101
- 239000007790 solid phase Substances 0.000 claims description 75
- 230000000295 complement effect Effects 0.000 claims description 55
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 238000002372 labelling Methods 0.000 claims description 32
- 239000000523 sample Substances 0.000 claims description 32
- 238000001514 detection method Methods 0.000 claims description 30
- 108020004414 DNA Proteins 0.000 claims description 29
- 238000006073 displacement reaction Methods 0.000 claims description 19
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 13
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 13
- 108091023037 Aptamer Proteins 0.000 claims description 10
- 239000012491 analyte Substances 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 8
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 8
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 8
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 8
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 108020004635 Complementary DNA Proteins 0.000 claims description 3
- 238000000691 measurement method Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims 4
- 239000002131 composite material Substances 0.000 claims 1
- 102000053602 DNA Human genes 0.000 description 28
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 25
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 20
- 238000005259 measurement Methods 0.000 description 20
- 238000010494 dissociation reaction Methods 0.000 description 15
- 108010090804 Streptavidin Proteins 0.000 description 14
- 229960002685 biotin Drugs 0.000 description 11
- 239000011616 biotin Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 10
- 235000020958 biotin Nutrition 0.000 description 10
- 230000005593 dissociations Effects 0.000 description 10
- -1 dinitrophenyl Chemical group 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000002860 competitive effect Effects 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 208000018459 dissociative disease Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 241000972773 Aulopiformes Species 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000000835 electrochemical detection Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 235000019515 salmon Nutrition 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- QAPSNMNOIOSXSQ-YNEHKIRRSA-N 1-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)C1 QAPSNMNOIOSXSQ-YNEHKIRRSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000009918 complex formation Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002848 electrochemical method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- BFTYVNASNGCVSQ-UHFFFAOYSA-N (4-methoxyphenyl) dihydrogen phosphate Chemical compound COC1=CC=C(OP(O)(O)=O)C=C1 BFTYVNASNGCVSQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 150000000918 Europium Chemical class 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003172 aldehyde group Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 238000004401 flow injection analysis Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940054192 micro-guard Drugs 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 102000014187 peptide receptors Human genes 0.000 description 1
- 108010011903 peptide receptors Proteins 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005274912A JP4839051B2 (ja) | 2004-10-08 | 2005-09-22 | 核酸プローブを用いる被検物質の検出方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004296329 | 2004-10-08 | ||
| JP2004296329 | 2004-10-08 | ||
| JP2005274912A JP4839051B2 (ja) | 2004-10-08 | 2005-09-22 | 核酸プローブを用いる被検物質の検出方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006129866A JP2006129866A (ja) | 2006-05-25 |
| JP2006129866A5 JP2006129866A5 (https=) | 2008-10-23 |
| JP4839051B2 true JP4839051B2 (ja) | 2011-12-14 |
Family
ID=36723918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005274912A Expired - Fee Related JP4839051B2 (ja) | 2004-10-08 | 2005-09-22 | 核酸プローブを用いる被検物質の検出方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4839051B2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2172566T4 (da) * | 2007-07-17 | 2022-06-13 | Somalogic Inc | Fremgangsmåde til generering af aptamerer med forbedrede off-rates |
| JP5071076B2 (ja) * | 2007-11-30 | 2012-11-14 | ソニー株式会社 | プローブを用いた結合検出方法 |
| JP5305254B2 (ja) * | 2009-03-17 | 2013-10-02 | 日本電気株式会社 | 標的物質の検出方法 |
| WO2010124157A1 (en) * | 2009-04-24 | 2010-10-28 | Ambit Biosciences Corporation | Cellular assay employing detectable protein |
| CA2968376C (en) * | 2014-11-21 | 2020-06-23 | Nanostring Technologies, Inc. | Enzyme- and amplification-free sequencing |
| KR102313431B1 (ko) | 2016-11-21 | 2021-10-18 | 나노스트링 테크놀로지스, 인크. | 화학적 조성물 및 이것을 사용하는 방법 |
| JP6949595B2 (ja) * | 2017-07-19 | 2021-10-13 | シスメックス株式会社 | 被検物質を検出する方法 |
| AU2019271028B2 (en) | 2018-05-14 | 2025-09-18 | Bruker Spatial Biology, Inc. | Chemical compositions and methods of using same |
| FR3094092B1 (fr) * | 2019-03-19 | 2021-04-09 | Univ Bordeaux | Capture de microvesicules a visee diagnostique |
| CN119780439B (zh) * | 2024-12-02 | 2025-11-04 | 中国计量大学 | 一种豆类凝集素提取设备及其微流控检测方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804384A (en) * | 1996-12-06 | 1998-09-08 | Vysis, Inc. | Devices and methods for detecting multiple analytes in samples |
| CA2379749A1 (en) * | 1999-07-16 | 2001-01-25 | Aclara Biosciences, Inc. | Multiplexed strand displacement for nucleic acid determinations |
| US20020146745A1 (en) * | 2001-04-03 | 2002-10-10 | Surromed, Inc. | Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples |
-
2005
- 2005-09-22 JP JP2005274912A patent/JP4839051B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006129866A (ja) | 2006-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102925377B1 (ko) | 면역검정 방법에서 사용을 위한 전기화학발광성 표지화된 프로브, 이의 사용 방법 및 이를 포함하는 키트 | |
| US20210403998A1 (en) | Chemical compositions and uses thereof | |
| EP1250463B1 (en) | Sensitive, multiplexed diagnostic assays for protein analysis | |
| EP0638807B1 (en) | Protection assay | |
| US7022479B2 (en) | Sensitive, multiplexed diagnostic assays for protein analysis | |
| US6004745A (en) | Hybridization protection assay | |
| EP0914467B1 (en) | Method for nucleic acid analysis | |
| US5639604A (en) | Homogeneous protection assay | |
| EP2172567A2 (en) | Methods for detecting nucleic acids in a sample | |
| JP2005521409A (ja) | 単一プライマー等温核酸増幅−増強型被分析物検出および定量 | |
| JP2022501005A (ja) | アッセイを改善する為の化合物、組成物、及び方法 | |
| JP4839051B2 (ja) | 核酸プローブを用いる被検物質の検出方法 | |
| EP1672082B1 (en) | A method for detecting a target substance using a nucleic acid probe | |
| CA3029178C (en) | Double-stranded nucleic acid signal probe and method for detecting target molecule using same | |
| CN113195722B (zh) | 与基孔肯雅热病毒e2特异性结合的dna适体及其用途 | |
| US11231420B2 (en) | Selection and optimization of aptamers to recognize ebola markers | |
| EP0649530B1 (en) | CHEMILUMINESCENT ASSAY FOR dsDNA ANTIBODIES | |
| US5871906A (en) | Method for detection of amplified nucleic acid products and related diagnostic assays | |
| Hashino et al. | Application of a lanthanide fluorescent chelate label for detection of single-nucleotide mutations with peptide nucleic acid probes | |
| US8216810B2 (en) | Multiplex systems, methods, and kits for detecting and identifying nucleic acids | |
| EP0421469A2 (en) | Method for separating nucleic acid | |
| JPH06113896A (ja) | 核酸の測定方法 | |
| JP7279633B2 (ja) | 核酸の検出方法 | |
| RU2497128C2 (ru) | Способ одновременного определения двух аналитов биолюминесцентным молекулярным микроанализом | |
| US20050239078A1 (en) | Sequence tag microarray and method for detection of multiple proteins through DNA methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080904 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080904 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110719 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110804 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110913 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111003 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141007 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |